Kenshiro Takemoto

12PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 06, 2026
KIF23 is associated with a poor prognosis, basal subtypes and immunotherapy response in urothelial carcinoma.

|Aug 06, 2026
RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.

|Jul 23, 2026
External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|Feb 26, 2026
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Yoshinori Nakano, Yohei Sekino, Go Kobayashi

|Jan 26, 2026
Genomic and Clinical Impact of Smoking on Therapeutic Outcomes in Prostate Cancer: A Public Databases Analysis.

Tomoya Hatayama, Yohei Sekino, Go Kobayashi

Pageof 2

Frequent Collaborators

12 joint publications

Nobuyuki Hinata

10 joint publications

Kohei Kobatake

8 joint publications

Miki Naito

8 joint publications

Shunsuke Miyamoto